Prophylactic use of antibiotics for prevention of meningococcal infections: Systematic review and meta-analysis of randomised trials

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 24, Issue 3, 2005, Pages 172-181

  Fraser, A ^a   Gafter Gvili, A ^a   Paul, M ^a   Leibovici, L ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BACAMPICILLIN; CEFALEXIN; CEFTRIAXONE; CIPROFLOXACIN; COUMAMYCIN A1; ERYTHROMYCIN; MINOCYCLINE; PENICILLIN G; PLACEBO; RIFAMPICIN; SPECTINOMYCIN; SULFADIAZINE; SULFADIMIDINE;

ABDOMINAL PAIN; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; CHI SQUARE TEST; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; DATA BASE; DIARRHEA; DRUG EFFICACY; EMBASE; ERADICATION THERAPY; HEADACHE; HUMAN; INJECTION PAIN; MEDLINE; MENINGOCOCCOSIS; META ANALYSIS; NAUSEA; NEISSERIA MENINGITIDIS; PHARYNX; PRIORITY JOURNAL; QUALITY CONTROL; RASH; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS;

EID: 17744364477     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-005-1297-7     Document Type: Review

References (59)

1. Ferguson LE, Hormann MD (2002) Neisseria meningitidis: presentation, treatment and prevention. J Pediatr Health Care 16:119-124
2. Bramley JC, Begg NT, Booy R, Buttery J, Finn A, Heath PT, Jones IG, Richmond PC, Rosenstein NE (1999) Conjugate vaccines for preventing meningococcal C meningitis and septicaemia. Cochrane database of systematic reviews, 1999, issue 4, article no. CD001834. DOI 10.1002/14651858.CD001834
3. Hanford S, Ramsay M, Fox A, and the Surveillance Network for Invasive Neisseria meningitidis in Europe. Final report, 1999 & 2000. Commission of the European Communities. http://www.euibis.org/documents/meningo19992000.pdf
4. Andersen J, Berthelsen L, Jensen BB et al (2000) Surveillance of cases of meningococcal disease associated with military recruits studied for meningococcal carriage. Scand J Infect Dis 32:527-531
5. World Health Organization. Meningococcal disease. http:// www.who.int/csr/disease/meningococcal/en/. Cited 30 May 2004
6. Public Health Laboratory Service Meningococcus Forum (2002) Guidelines for public health management of meningoccocal disease in the UK. Commun Dis Public Health 5:187-204
7. Girgis N, Sultan Y, Frenck RW Jr et al (1998) Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria meningitidis. Pediatr Infect Dis J 17:816-819
8. Centers for Disease Control and Prevention (2000) Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR. Recomm Rep 49(RR07):1-10
9. Fraser A, Gafter-Gvili A, Paul M, Leibovici L (2005) Antibiotics for preventing meningococcal infections. Cochrane database of systematic reviews, 2005, issue 1, article no. CD004785. DOI 10.1002/14651858.CD004785.pub2
10. Gaunt PN (1988) Ciprofloxacin vs ceftriaxone for eradication of meningococcal carriage. Lancet ii(8604):218-219
11. Wall AR, Grunberg RN (1982) Rifampicin and erythromycin for the meningococcal carrier. Lancet ii(8311):1346
12. Artenstein MS, Lamson TH, Evans JR (1967) Attempted prophylaxis against meningococcal infection using intramuscular penicillin. Mil Med 132:1009-1011
13. Cardenas AT, Contreras AG, Rojas CQ (1995) Cefixima para quimioprofilaxis antimeningococica [Cefixime in meningococcal disease chemoprophylaxis]. Rev Chil Pediatr 66:217-219
14. Fairbrother RW (1940) Cerebrospinal meningitis: the use of sulphonamide derivatives in prophylaxis. Brit Med J 2:859-862
15. Gilja OH, Halstensen A, Digranes A et al (1993) Use of single-dose ofloxacin to eradicate tonsillopharyngeal carriage of Neisseria meningitidis. Antimicrob Agents Chemother 37:2024-2026
16. Halstensen A, Gilja OH, Digranes A et al (1995) Single-dose ofloxacin in the eradication of pharyngeal carriage of Neisseria meningitidis. Drugs 49(Suppl 2):399-400
17. Sanders E (1967) Use of sulfonamide carbonic anhydrase inhibitors in treatment of meningococcal carriers: rationale and report of a clinical trial of ethoxzolamide. Am J Med Sci 254:709-716
18. Shehab S, Leitner L, Bogokowsky B et al (1991) Alternating rifampicin and ceftriaxone for Neisseria meningitidis eradication in contacts. Harefuah 120:641-643
19. Potter PC, Frasch CE, van der Sande WJ et al (1990) Prophylaxis against Neisseria meningitidis infections and antibody responses in patients with deficiency of the sixth component of complement. J Infect Dis 161:932-937
20. Band JD, Fraser DW (1984) Adverse effects of two rifampicin dosage regimens for the prevention of meningococcal infection. Lancet i(8368):101-102
21. Beam WE Jr, Newberg NR, Devine LF et al (1971) The effect of rifampin on the nasopharyngeal carriage of Neisseria meningitidis in a military population. J Infect Dis 124:39-46
22. Beaty HN (1983) Rifampin and minocycline in meningococcal disease. Rev Infect Dis 5(Suppl 3):S451-S458
23. Chapalain JC, Guibourdenche M, Perrier Gros Claude JD et al (1992) The chemoprophylaxis of cerebrospinal meningitis using rifampin in a military population. Pathol Biol 40:230-233
24. Cheever FS, Breeses BB, Upham HC (1943) The treatment of meningococcus carriers with sulfadiazine. Ann Int Med 19:602-608
25. Devine LF, Springer GL, Frazier WE et al (1972) Selective minocycline and rifampin treatment of group C meningococcal carriers in a new naval recruit camp. Am J Med Sci 263:79-93
26. Devine LF, Pollard RB, Krumpe PE et al (1973) Field trial of the efficacy of a previously proposed regimen using minocycline and rifampin sequentially for the elimination of meningococci from healthy carriers. Am J Epidemiol 97:394-401
27. Gonzalez de Aledo Linos A, Garcia Merino J (2000) Control de un brote escolar de enfermedad meningococica serogrupo B mediante quimioprofilaxis con azitromicina y ciprofloxacino [Control of a school outbreak of serogroup B meningococcal disease by chemoprophylaxis with azithromycin and ciprofloxacin]. An Esp Pediatr 53:412-417
28. Gray FC, Gear J (1941) Sulphapyridine M & B 693 as a prophylactic against cerebrospinal meningitis. South Afr Med J 15:139-140
29. Kuhns DM, Nelson CT, Feldman HA, Kuhn LR (1943) The prophylactic value of sulfadiazine. JAMA 123:335-339
30. Sivonen A, Renkonen OV, Weckstrom P et al (1978) The effect of chemoprophylactic use of rifampin and minocycline on rates of carriage of Neisseria meningitidis in army recruits in Finland. J Infect Dis 137:238-244
31. Weidmer CE, Dunkel TB, Pettyjohn FS et al (1971) Effectiveness of rifampin in eradicating the meningococcal carrier state in a relatively closed population: emergence of resistant strains. J Infect Dis 124:172-178
32. Hart CA, Cuevas LE, Kazembe P et al (1992) The use of ciprofloxacin to eradicate oropharyngeal carriage of Neisseria meningitidis: a preliminary report. Adv Antimicr Antineopl Chemother 11:167-171
33. Schwartz B (1991) Chemoprophylaxis for bacterial infections: principles of and application to meningoccocal infections. Rev Infect Dis 13(Suppl 2):S170-S173
34. Simmons G, Jones N, Calder L (1999) Comparison of ceftriaxone and rifampicin in eliminating nasopharyngeal carriage of serogroup B Neisseria meningitidis. Aust N Z J Med 29:587
35. Blakebrough IS, Gilles HM (1980) The effect of rifampicin on meningococcal carriage in family contacts in northern Nigeria. J Infect 2:137-143
36. Cuevas LE, Kazembe P, Mughogho GK et al (1995) Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: a comparison of ciprofloxacin and rifampicin. J Infect Dis 171:728-731
37. Borgono JM, Rodriguez H, Garcia J et al (1981) Eficacia de la rifampicina en el tratamiento de los portadores de meningococo [Efficacy of rifampicin in the treatment of meningococcus carriers]. Rev Chil Pediatr 52:146-148
38. Deal WB, Sanders E (1969) Efficacy of rifampin in treatment of meningococcal carriers. N Engl J Med 281:641-645
39. Deal WB, Sanders E (1969) Therapeutic trial of cephalexin in meningococcal carriers. Antimicrob Agents Chemother 9:441-444
40. Deviatkina NP, Demina AA, Orlova EV (1978) Otsenka saniruiushchego deistviia rifampitsina na nositel'stvo meningokokkov [Evaluation of the sanative action of rifampicin on the meningococcal carrier state]. Antibiotiki 23:794-797
41. Devine LF, Johnson DP, Hagerman CR et al (1970) Rifampin levels in serum and saliva and effect on the meningoccocal carrier state. JAMA 214:1055-1059
42. Devine LF, Johnson DP, Hagerman CR et al (1971) The effect of minocycline on meningococcal nasopharyngeal carrier state in naval personnel. Am J Epidemiol 93:337-345
43. Devine LF, Johnson DP, Hagerman CR (1970) The effect of coumermycin A on the meningococcal carrier state. Am J Med Sci 260:165-170
44. Dowd JM, Blink D, Miller CH et al (1966) Antibiotic prophylaxis of carriers of sulfadiazine-resistant meningococci. J Infect Dis 116:473-480
45. Dworzack DL, Sanders CC, Horowitz EA et al (1988) Evaluation of single-dose ciprofloxacin in the eradication of Neisseria meningitidis from nasopharyngeal carriers. Antimicrob Agents Chemother 32:1740-1741
46. Edwards LD, Gartner T (1984) Comparison between bacampicillin and amoxycillin in treating genital and extragenital infection with Neisseria gonorrhoeae and pharyngeal infection with Neisseria meningitidis. Br J Vener Dis 60:380-383
47. Guttler RB, Counts GW, Avent CK et al (1971) Effect of rifampin and minocycline on meningococcal carrier rates. J Infect Dis 124:199-205
48. Judson FN, Ehret JM (1984) Single-dose ceftriaxone to eradicate pharyngeal Neisseria meningitidis. Lancet ii(8417-8):1462-1463
49. Kaiser AB, Hennekens CH, Saslaw MS et al (1974) Seroepidemiology and chemoprophylaxis of disease due to sulfonamide-resistant Neisseria meningitidis in a civilian population. J Infect Dis 130:217-224
50. Kaya A, Tasyaran MA, Celebi S et al (1997) Efficacy of a single dose of ciprofloxacin vs. rifampicin in eradicating the nasopharyngeal carriage of Neisseria meningitidis. Turk J Med Sci 27:153-155
51. Munford RS, de Vasconcelos ZJS, Philips CJ et al (1974) Eradication of carriage of Neisseria meningitidis in families: a study in Brazil. J Infect Dis 129:644-649
52. Pugsley MP, Dworzack DL, Sanders CC et al (1984) Evaluation of Sch 29,482 in the eradication of Neisseria meningitidis from nasopharyngeal carriers. Antimicrob Agents Chemother 25:494-496
53. Pugsley MP, Dworzack DL, Horowitz EA et al (1987) Efficacy of ciprofloxacin in the treatment of nasopharyngeal carriers of Neisseria meningitidis. J Infect Dis 156:211-213
54. Renkonen OV, Sivonen A, Visakorpi R (1987) Effect of ciprofloxacin on carrier rate of Neisseria meningitidis in army recruits in Finland. Antimicrob Agents Chemother 31:962-963
55. Schwartz B, Al Tobaiqi A, Al Ruwais A et al (1988) Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria menitigitidis. Lancet i(8597):1239-1242
56. Simmons G, Jones N, Calder L (2000) Equivalence of ceftriaxone and rifampicin in eliminating nasopharyngeal carriage of serogroup B Neisseria meningitidis. J Antimicrob Chemother 45:909-911
57. Purcell B, Samuelsson S, Hahne SJ, Ehrhard I, Heuberger S, Camaroni I, Charlett A, Stuart JM (2004) Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review. BMJ 328:1339-1343
58. Hart CA, Rogers TRF (1993) Meningococcal disease. J Med Microbiol 39:3-25
59. Carter PE, Abadi FJ, Yakubu DE et al (1994) Molecular characterization of rifampin-resistant Neisseria meningitidis. Antimicrob Agents Chemother 38:1256-1261